Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial-Reference-Cited by-同舟云学术

Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial

Published:2021-01 Issue:1 Volume:9 Page:57-68
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Heaney Liam G,Busby John,Hanratty Catherine E,Djukanovic Ratko,Woodcock Ashley,Walker Samantha M,Hardman Timothy C,Arron Joseph R,Choy David F,Bradding Peter,Brightling Christopher E,Chaudhuri Rekha,Cowan Douglas C,Mansur Adel H,Fowler Stephen J,Niven Robert M,Howarth Peter H,Lordan James L,Menzies-Gow Andrew,Harrison Tim W,Robinson Douglas S,Holweg Cecile T J,Matthews John G,Pavord Ian D,Adcock Ian M,Azim Adnam,Bellamy Mary,Borg Catherine,Bourne Michelle,Connolly Clare,Costello Richard W,Corrigan Chris J,Davies Sarah,Davies Gareth,Chung Kian F,Gainsborough Gabrielle,Grandison Traceyanne,Hargadon Beverley,Horn Avril,Hudson Val,Jackson David,Johnston Sebastian,Jones Geraldine,McCourt Paula,Nunez Maria,Shaw Dominic E,Smith Katherine,Solis Joel,Stone Roisin,Yang Freda

Funder

GlaxoSmithKline

Chiesi Farmaceutici

Genentech

Medical Research Council

AstraZeneca

F. Hoffmann-La Roche

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference19 articles.

1. Non-eosinophilic corticosteroid unresponsive asthma;Pavord;Lancet,1999

2. T-helper type 2-driven inflammation defines major subphenotypes of asthma;Woodruff;Am J Respir Crit Care Med,2009

3. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic;McGrath;Am J Respir Crit Care Med,2012

4. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry;Sweeney;Thorax,2016

5. Systematic literature review of systemic corticosteroid use for asthma management;Bleecker;Am J Respir Crit Care Med,2019

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Economic Burden of Severe Asthma With Low Blood Eosinophil Counts;The Journal of Allergy and Clinical Immunology: In Practice;2024-07

2. Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics;The Journal of Allergy and Clinical Immunology: In Practice;2024-04

3. New targets for type 2-low asthma;The Korean Journal of Internal Medicine;2024-03-01

4. Update in paediatric asthma 2024;Pediatric Respirology and Critical Care Medicine;2024-01

5. Fractional exhaled nitric oxide (FeNO): the future of asthma care?;British Journal of General Practice;2023-11-30